228 related articles for article (PubMed ID: 21269472)
1. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
[TBL] [Abstract][Full Text] [Related]
2. Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer.
Wirtenberger M; Tchatchou S; Hemminki K; Schmutzhard J; Sutter C; Schmutzler RK; Meindl A; Wappenschmidt B; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
Carcinogenesis; 2006 Nov; 27(11):2201-8. PubMed ID: 16704985
[TBL] [Abstract][Full Text] [Related]
3. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
[TBL] [Abstract][Full Text] [Related]
4. C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.
Yamamoto-Ibusuki M; Yamamoto Y; Fujiwara S; Sueta A; Yamamoto S; Hayashi M; Tomiguchi M; Takeshita T; Iwase H
Eur J Hum Genet; 2015 Jul; 23(7):949-56. PubMed ID: 25370037
[TBL] [Abstract][Full Text] [Related]
5. Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
Ghali RM; Al-Mutawa MA; Al-Ansari AK; Zaied S; Bhiri H; Mahjoub T; Almawi WY
Gene; 2018 Apr; 651():194-199. PubMed ID: 29414691
[TBL] [Abstract][Full Text] [Related]
6. ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.
Dunbier AK; Anderson H; Ghazoui Z; Lopez-Knowles E; Pancholi S; Ribas R; Drury S; Sidhu K; Leary A; Martin LA; Dowsett M
PLoS Genet; 2011 Apr; 7(4):e1001382. PubMed ID: 21552322
[TBL] [Abstract][Full Text] [Related]
7. Genetic effect of single-nucleotide polymorphisms in the PPARGC1B gene on airway hyperreactivity in asthmatic patients.
Lee SH; Jang AS; Woo Park S; Park JS; Kim YK; Uh ST; Kim YH; Chung IY; Park BL; Shin HD; Park CS
Clin Exp Allergy; 2011 Nov; 41(11):1533-44. PubMed ID: 21692888
[TBL] [Abstract][Full Text] [Related]
8. Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
Kawada K; Taira N; Mizoo T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kochi M; Abe Y; Nishiyama K; Iwamoto T; Ikeda H; Shien T; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Toyooka S
Breast Cancer; 2021 Mar; 28(2):478-487. PubMed ID: 33185851
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer.
O'Mara TA; Glubb DM; Painter JN; Cheng T; Dennis J; ; Attia J; Holliday EG; McEvoy M; Scott RJ; Ashton K; Proietto T; Otton G; Shah M; Ahmed S; Healey CS; Gorman M; Martin L; ; Hodgson S; Fasching PA; Hein A; Beckmann MW; Ekici AB; Hall P; Czene K; Darabi H; Li J; Dürst M; Runnebaum I; Hillemanns P; Dörk T; Lambrechts D; Depreeuw J; Annibali D; Amant F; Zhao H; Goode EL; Dowdy SC; Fridley BL; Winham SJ; Salvesen HB; Njølstad TS; Trovik J; Werner HM; Tham E; Liu T; Mints M; ; Bolla MK; Michailidou K; Tyrer JP; Wang Q; Hopper JL; ; Peto J; Swerdlow AJ; Burwinkel B; Brenner H; Meindl A; Brauch H; Lindblom A; Chang-Claude J; Couch FJ; Giles GG; Kristensen VN; Cox A; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Thompson DJ; Spurdle AB
Endocr Relat Cancer; 2015 Oct; 22(5):851-61. PubMed ID: 26330482
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.
Shenker NS; Flower KJ; Wilhelm-Benartzi CS; Dai W; Bell E; Gore E; El Bahrawy M; Weaver G; Brown R; Flanagan JM
BMC Cancer; 2015 May; 15():337. PubMed ID: 25927974
[TBL] [Abstract][Full Text] [Related]
11. R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.
Boldes T; Merenbakh-Lamin K; Journo S; Shachar E; Lipson D; Yeheskel A; Pasmanik-Chor M; Rubinek T; Wolf I
BMC Cancer; 2020 Jun; 20(1):531. PubMed ID: 32513126
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Dunning AM; Michailidou K; Kuchenbaecker KB; Thompson D; French JD; Beesley J; Healey CS; Kar S; Pooley KA; Lopez-Knowles E; Dicks E; Barrowdale D; Sinnott-Armstrong NA; Sallari RC; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Hills M; Jarosz M; Drury S; Canisius S; Bolla MK; Dennis J; Wang Q; Hopper JL; Southey MC; Broeks A; Schmidt MK; Lophatananon A; Muir K; Beckmann MW; Fasching PA; Dos-Santos-Silva I; Peto J; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; González-Neira A; Perez JI; Anton-Culver H; Eunjung L; Arndt V; Brenner H; Meindl A; Schmutzler RK; Brauch H; Hamann U; Aittomäki K; Blomqvist C; Ito H; Matsuo K; Bogdanova N; Dörk T; Lindblom A; Margolin S; Kosma VM; Mannermaa A; Tseng CC; Wu AH; Lambrechts D; Wildiers H; Chang-Claude J; Rudolph A; Peterlongo P; Radice P; Olson JE; Giles GG; Milne RL; Haiman CA; Henderson BE; Goldberg MS; Teo SH; Yip CH; Nord S; Borresen-Dale AL; Kristensen V; Long J; Zheng W; Pylkäs K; Winqvist R; Andrulis IL; Knight JA; Devilee P; Seynaeve C; Figueroa J; Sherman ME; Czene K; Darabi H; Hollestelle A; van den Ouweland AM; Humphreys K; Gao YT; Shu XO; Cox A; Cross SS; Blot W; Cai Q; Ghoussaini M; Perkins BJ; Shah M; Choi JY; Kang D; Lee SC; Hartman M; Kabisch M; Torres D; Jakubowska A; Lubinski J; Brennan P; Sangrajrang S; Ambrosone CB; Toland AE; Shen CY; Wu PE; Orr N; Swerdlow A; McGuffog L; Healey S; Lee A; Kapuscinski M; John EM; Terry MB; Daly MB; Goldgar DE; Buys SS; Janavicius R; Tihomirova L; Tung N; Dorfling CM; van Rensburg EJ; Neuhausen SL; Ejlertsen B; Hansen TV; Osorio A; Benitez J; Rando R; Weitzel JN; Bonanni B; Peissel B; Manoukian S; Papi L; Ottini L; Konstantopoulou I; Apostolou P; Garber J; Rashid MU; Frost D; ; Izatt L; Ellis S; Godwin AK; Arnold N; Niederacher D; Rhiem K; Bogdanova-Markov N; Sagne C; Stoppa-Lyonnet D; Damiola F; ; Sinilnikova OM; Mazoyer S; Isaacs C; Claes KB; De Leeneer K; de la Hoya M; Caldes T; Nevanlinna H; Khan S; Mensenkamp AR; ; Hooning MJ; Rookus MA; Kwong A; Olah E; Diez O; Brunet J; Pujana MA; Gronwald J; Huzarski T; Barkardottir RB; Laframboise R; Soucy P; Montagna M; Agata S; Teixeira MR; ; Park SK; Lindor N; Couch FJ; Tischkowitz M; Foretova L; Vijai J; Offit K; Singer CF; Rappaport C; Phelan CM; Greene MH; Mai PL; Rennert G; Imyanitov EN; Hulick PJ; Phillips KA; Piedmonte M; Mulligan AM; Glendon G; Bojesen A; Thomassen M; Caligo MA; Yoon SY; Friedman E; Laitman Y; Borg A; von Wachenfeldt A; Ehrencrona H; Rantala J; Olopade OI; Ganz PA; Nussbaum RL; Gayther SA; Nathanson KL; Domchek SM; Arun BK; Mitchell G; Karlan BY; Lester J; Maskarinec G; Woolcott C; Scott C; Stone J; Apicella C; Tamimi R; Luben R; Khaw KT; Helland Å; Haakensen V; Dowsett M; Pharoah PD; Simard J; Hall P; García-Closas M; Vachon C; Chenevix-Trench G; Antoniou AC; Easton DF; Edwards SL
Nat Genet; 2016 Apr; 48(4):374-86. PubMed ID: 26928228
[TBL] [Abstract][Full Text] [Related]
13. Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
Muthukaruppan A; Lasham A; Woad KJ; Black MA; Blenkiron C; Miller LD; Harris G; McCarthy N; Findlay MP; Shelling AN; Print CG
Clin Breast Cancer; 2017 Apr; 17(2):139-153. PubMed ID: 27756582
[TBL] [Abstract][Full Text] [Related]
14. Diverse associations between ESR1 polymorphism and breast cancer development and progression.
Ding SL; Yu JC; Chen ST; Hsu GC; Hsu HM; Ho JY; Lin YH; Chang CC; Fann CS; Cheng CW; Wu PE; Shen CY
Clin Cancer Res; 2010 Jul; 16(13):3473-84. PubMed ID: 20570923
[TBL] [Abstract][Full Text] [Related]
15. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
[TBL] [Abstract][Full Text] [Related]
16. ESR1 and EGF genetic variation in relation to breast cancer risk and survival.
Einarsdóttir K; Darabi H; Li Y; Low YL; Li YQ; Bonnard C; Sjölander A; Czene K; Wedrén S; Liu ET; Hall P; Humphreys K; Liu J
Breast Cancer Res; 2008; 10(1):R15. PubMed ID: 18271972
[TBL] [Abstract][Full Text] [Related]
17. Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer.
Jeon S; Choi JY; Lee KM; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2010 Jun; 121(3):737-42. PubMed ID: 19941161
[TBL] [Abstract][Full Text] [Related]
18. Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population.
Yang W; He X; He C; Peng L; Xing S; Li D; Wang L; Jin T; Yuan D
Clin Breast Cancer; 2021 Jun; 21(3):e235-e242. PubMed ID: 33281037
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
[TBL] [Abstract][Full Text] [Related]
20. The association between a novel polymorphism (rs1062577) in ESR1 and breast cancer susceptibility in the Han Chinese women.
Chen L; Kang H; Jin GJ; Chen X; Zhang QY; Lao WT; Li R
Gynecol Endocrinol; 2016 Jul; 32(7):553-6. PubMed ID: 26850117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
